Cargando…
Developmental Landscape of Potential Vaccine Candidates Based on Viral Vector for Prophylaxis of COVID-19
Severe acute respiratory syndrome coronavirus 2, SARS-CoV-2, arose at the end of 2019 as a zoonotic virus, which is the causative agent of the novel coronavirus outbreak COVID-19. Without any clear indications of abatement, the disease has become a major healthcare threat across the globe, owing to...
Autores principales: | Bezbaruah, Rajashri, Borah, Pobitra, Kakoti, Bibhuti Bhushan, Al-Shar’I, Nizar A., Chandrasekaran, Balakumar, Jaradat, Da’san M. M., Al-Zeer, Munir A., Abu-Romman, Saeid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082173/ https://www.ncbi.nlm.nih.gov/pubmed/33937326 http://dx.doi.org/10.3389/fmolb.2021.635337 |
Ejemplares similares
-
Perspectives on RNA Vaccine Candidates for COVID-19
por: Borah, Pobitra, et al.
Publicado: (2021) -
Neurological Consequences of SARS-CoV-2 Infection and Concurrence of Treatment-Induced Neuropsychiatric Adverse Events in COVID-19 Patients: Navigating the Uncharted
por: Borah, Pobitra, et al.
Publicado: (2021) -
Therapeutic drug repositioning with special emphasis on neurodegenerative diseases: Threats and issues
por: Kakoti, Bibhuti Bhusan, et al.
Publicado: (2022) -
In vitro anti-TB properties, in silico target validation, molecular docking and dynamics studies of substituted 1,2,4-oxadiazole analogues against Mycobacterium tuberculosis
por: Deb, Pran Kishore, et al.
Publicado: (2021) -
Adenoviral Vector-Based Vaccine Platform for COVID-19: Current Status
por: Chavda, Vivek P., et al.
Publicado: (2023)